Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable ...

For anyone who wants to understand Labcorp Holdings' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$131m due to ...

Study Progresses to Fourth Higher 90 mg/m 2 Dose Cohort Compelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast Count After One Treatment Cycle HOUSTON, Feb. 12, ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Baron Small Cap Fund highlighted stocks like Vertiv Holdings Co (NYSE:VRT), in the fourth quarter 2024 ...

Copa Holdings' unique business model and impressive profitability make it a buy, despite recent revenue challenges due to currency fluctuations and fleet issues. FY'24 earnings were solid with ...

FBN Holdings Plc, a financial holding company, has announced a change in its brand name to First HoldCo Plc, FirstHoldco. A statement from the firm on Tuesday stated that the rebranding would be ...

For anyone who wants to understand Labcorp Holdings' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$131m due to ...

MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Baron Small Cap Fund highlighted stocks like Vertiv Holdings Co (NYSE:VRT), in the fourth quarter 2024 investor ...

I’m not sure if an upcoming game has had release dates and windows leaked more (through official channels, no less) than Metal Gear Solid Delta Snake Eater. The long awaited remake of MGS 3 ...

Bio-Path Holdings, Inc. announced positive developments ... we were thrilled to see that our first patient treated with the higher dose (90 mg/m ) in our Phase 1/1b study of BP1001-A who has ...